Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women

Bone

Volumn 40, Issue 1, 2007, Pages 218-222

  Alexandersen, Peter ^a   Karsdal, M A ^b   Qvist, Per ^c   Reginster, J Y ^d   Christiansen, Claus ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^b Pharmos Bioscience   (Denmark)

^c NORDIC BIOSCIENCE A S   (Denmark)

^d Service de Santé Publique d'Epidémiologie et Économie de la Santé   (Belgium)

Author keywords

CTX II; Postmenopausal women; RCT; Strontium ranelate; Type II collagen degradation

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; COLLAGEN TYPE 2; PLACEBO; STRONTIUM RANELATE; VITAMIN D;

AGED; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; FEMALE; FRAGILITY FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; OSTEOPOROSIS; PATIENT COMPLIANCE; POSTMENOPAUSE; STATISTICAL SIGNIFICANCE; URINALYSIS; URINE LEVEL;

BIOLOGICAL MARKERS; CARTILAGE; CLINICAL TRIALS, PHASE III; COLLAGEN TYPE II; FEMALE; HUMANS; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS; THIOPHENES;

EID: 33845191832     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.07.028     Document Type: Article

References (15)

1. Creamer P., and Hochberg M.C. Osteoarthritis. Lancet 350 (1997) 503-508
2. Hayami T., Pickarski M., Wesolowski G.A., Mclane J., Bone A., Destefano J., et al. The role of subchondral bone remodelling in osteoarthritis. Arthritis Rheum. 50 (2004) 1193-1206
3. Ham K.D., Loeser R.F., Lindgren B.R., and Carlson C.S. Effects of long-term estrogen replacement therapy on osteoarthritis severity in cynomolgus monkeys. Arthritis Rheum. 46 (2002) 1956-1964
4. Ham K.D., and Carlson C.S. Effects of estrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized cynomolgus monkeys. J. Bone Miner. Res. 19 (2004) 823-829
5. Reijman M., Hazes J.M., Bierma-Zeinstra S.M., Koes B.W., Christgau S., Christiansen C., et al. A new marker of osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum. 50 (2004) 2471-2478
6. Garnero P., Conrozier T., et al. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann. Rheum. Dis. 62 (2003) 939-943
7. Sondergaard B.C., Henriksen K., Wulf H., Oestergaard S., Schurigt U., Brauer R., et al. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Osteoarthr. Cartil. (2006) 14:738-48
8. Garnero P., Peterfy C., Zaim S., and Schoenharting M. Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis. Arthritis Rheum. 52 (2005) 2822-2829
9. Meunier O.J., Roux C., Seeman E., Ortolani S., Badurski J.E., Spector T.D., et al. The effect of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N. Engl. J. Med. 350 (2004) 458-459
10. Reginster J.Y., Seeman E., De Vernejoul M.C., Adami S., Compston J., Phenekos C., et al. Strontium ranelate reduces the risk of nonvertebral fractures in post-menopausal women with osteoporosis: TROPOS study. J. Clin. Endocr. Metab. 90 (2005) 2816-2822
11. Henrotin Y., Labasse A., Zheng S.X., Galais P., Tsouderos Y., Crielaard J.M., et al. Strontium ranelate increases cartilage matrix formation. J. Bone Miner. Res. 16 (2001) 299-308
12. Garnero P. Osteoarthritis: biological markers for the future?. Jt. Bone Spine 69 (2002) 525-530
13. Dequeker J., Boonen N., Aerssens J., and Westhovens R. Inverse relationship osteoarthritis-osteoporosis: what is the evidence?. Br. J. Rheumatol. 35 (1996) 813-820
14. Marie P.J., Ammann P., Boivin G., and Rey C. Mechanisms of action and therapeutic potential of strontium in bone. Calcif. Tissue Int. 69 (2001) 121-129
15. Canalis E., Hott M., Deloffre P., Tsouderos Y., and Marie P.J. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 18 (1996) 517-523